文献速递甲状腺疾病

良性甲状腺结节与恶性甲状腺结节的生长速率差异

Differential Growth Rates of Benign vs. Malignant Thyroid Nodules.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

这项前瞻性队列研究对经组织学诊断的良性(1363个)与恶性(126个)甲状腺结节(≥1 cm)进行重复超声评估,中位超声间隔约21个月。恶性结节以>2 mm/y生长的相对危险度是良性结节的2.5倍(RR=2.5,95%CI 1.6–3.1,P<0.001),且生长>2 mm/y的恶性结节更具侵袭性。

要点

  • 恶性结节较良性结节更易以>2 mm/y速度生长(RR=2.5,95%CI 1.6–3.1,P<0.001)。
  • 校正临床因素后,恶性结节与>2 mm/y生长的关联依然存在。
  • 生长>2 mm/y的恶性结节病理风险更高:中危OR=2.99,高危OR=8.69。

核心结论

  • 恶性结节尤其是高危表型者比良性结节生长更快。
  • 生长>2 mm/y可预测恶性而非良性病变,该临床参数可辅助甲状腺癌风险评估。

研究设计与样本

  • 前瞻性队列研究,纳入经组织学诊断良性或恶性疾病且间隔≥6个月重复超声评估的患者。
  • 恶性结节126个,良性结节1363个,均≥1 cm。
  • 采用回归模型评估生长的预测因素。

主要发现

  • 恶性结节与良性结节的中位超声间隔相似(良性21.8个月,恶性20.9个月)。
  • 恶性结节较良性结节更易生长>2 mm/y(RR=2.5,95%CI 1.6–3.1,P<0.001),校正临床因素后仍成立。
  • 结节生长速度越快,其为恶性的相对危险度越高。
  • 生长>2 mm/y的恶性结节具有更高侵袭性癌症的比值比:中危OR=2.99(95%CI 1.20–7.47,P=0.03),高危OR=8.69(95%CI 1.78–42.34,P=0.02)。

临床怎么用

  • 原文结论指出生长>2 mm/y可辅助甲状腺癌风险评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Thyroid nodule growth was once considered concerning for malignancy, but data showing that benign nodules grow questioned the use of this paradigm. To date, however, no studies have adequately evaluated whether growth rates differ in malignant vs. benign nodules. OBJECTIVE: To sonographically evaluate growth rates in benign and malignant thyroid nodules ≥1 cm. DESIGN: Prospective, cohort study of patients with tissue diagnosis of benign or malignant disease, with repeated ultrasound evaluation six or more months apart. MAIN OUTCOMES: Growth rate in largest dimension of malignant compared with benign thyroid nodules. Regression models were used to evaluate predictors of growth. RESULTS: Malignant nodules (126) met inclusion criteria (≥6-month nonoperative followup) and were compared with 1363 benign nodules. Malignant nodules were not found to be uniquely selected or prospectively observed solely for low-risk phenotype. Median ultrasound intervals were similar (21.8 months for benign nodules; 20.9 months for malignant nodules). Malignant nodules were more likely to grow >2 mm/y compared with benign nodules [relative risk (RR) = 2.5, 95% confidence interval (CI), 1.6 to 3.1; P < 0.001], which remained true after adjustment for clinical factors. The RR of a nodule being malignant increased with faster growth rates. Malignant nodules growing >2 mm/y had greater odds of being more aggressive cancers [intermediate risk: odds ratio (OR) = 2.99; 95% CI, 1.20 to 7.47; P = 0.03; higher risk: OR = 8.69; 95% CI, 1.78 to 42.34; P = 0.02]. CONCLUSIONS: Malignant nodules, especially higher-risk phenotypes, grow faster than benign nodules. As growth >2 mm/y predicts malignant compared with benign disease, this clinical parameter can contribute to the assessment of thyroid cancer risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Angell TE, Vyas CM, Medici M, et al. Differential Growth Rates of Benign vs. Malignant Thyroid Nodules. J Clin Endocrinol Metab. 2017. PMID: 29040691. doi:10.1210/jc.2017-01832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。